Springer Nature
Browse
12967_2018_1668_MOESM2_ESM.docx (15.16 kB)

MOESM2 of Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma

Download (15.16 kB)
journal contribution
posted on 2018-10-24, 05:00 authored by David Borg, Anna Larsson, Charlotta Hedner, Bjรถrn Nodin, Anders Johnsson, Karin Jirstrรถm
Additional file 2: Table S2. Correlation and conversion of PODXL expression between paired tissue samples in the neoadjuvant cohort.

Funding

Cancerfonden (SE)

History

Usage metrics

    Journal of Translational Medicine

    Categories

    Keywords

    Esophageal adenocarcinomaGastric adenocarcinomaNeoadjuvant chemotherapyPODXL

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC